![](/img/cover-not-exists.png)
436 Monitoring activity of RXDX-101 in Phase 1/2 patients using a pharmacodynamic assay for TrkA activation
Murphy, D., Ely, H., Patel, R., Wei, G., Diliberto, A., Shoemaker, R., Christiansen, J.Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70562-3
Date:
November, 2014
File:
PDF, 73 KB
english, 2014